Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2025-12-24 @ 9:10 PM
NCT ID:
NCT00015704
Eligibility Criteria:
Inclusion Criteria:
* HIV infected
* On stable, potent ART regimen for at least 3 months prior to study entry
* Viral load of less than 400 copies/ml for at least 6 months prior to study entry
* Viral load of less than 200 copies/ml at screening
* CD4 count of 500 cells/mm3 or greater at screening
* Agree to use acceptable methods of contraception
* Agree to be followed on this study for at least 4 years
* Primary care provider willing to have the patient in the study and to comply with study guidelines
Exclusion Criteria:
* Active or past significant AIDS-related illness. Patients with a history of minimal (less than 10 lesions) cutaneous Kaposi's sarcoma, pulmonary tuberculosis, or bacterial pneumonia are not excluded.
* Immunomodulators within 1 month of study entry
* Hydroxyurea within 3 months of study entry
* Prior IL-2 treatment
* Drugs to treat heart disease within 30 days of study entry
* Serious heart problems
* Cancer requiring anti-cancer drugs
* Thyroid problems. If the condition has been controlled by drugs for at least 3 months prior to study entry, the patient is not excluded.
* Uncontrolled diabetes
* Breathing or stomach problems that, in the opinion of the investigator, may affect the safety of the patient
* History of autoimmune disease, including inflammatory bowel disease, psoriasis, and optic neuritis
* Organ transplant
* History of neurological disorder or mental illness that, in the opinion of the investigator, may interfere with study requirements
* Alcohol or drug abuse that, in the opinion of the investigator, may interfere with study requirements
* Astemizole, midazolam, or triazolam within 2 weeks of study entry
* Systemic corticosteroids for 4 weeks or more within 3 months of study entry
* Pregnancy or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00015704
Study Brief:
Protocol Section:
NCT00015704